• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

NovaBay Pharmaceuticals to distribute Okra Limited’s dry eye products

August 19, 2021 By Sean Whooley

NovaBay PharmaceuticalsNovaBay Pharmaceuticals (NYSE:NBY) announced today that it agreed with Okra Limited to distribute its Zocular dry eye products.

The agreement allows NovaBay to distribute Zocular dry eye products alongside Avenova in its physician-dispensed sales channel.

Zocular products are formulated with patented Zokrex technology, which contains activated natural okra polysaccharide complexes designed to gently and effectively clear Demodex, scurf and residue from eyelids. They include easy-to-use, in-office and at-home treatment options.

The ZocuKit for ZEST (Zocular Eyelid System Technology) provides a 10-minute, in-office procedure that is clinically proven to offer dramatic, immediate lasting results for dry eye. ZEST requires no capital equipment or topical anaesthetic, according to a news release.

Additionally, Okra offers ZocuWipe, a once-daily, disposable towel for neutralizing and removing dirt, oil and debris, ZocuFoam, a gentle eyelid cleaning and moisturizing foam and finally ZocuShield, an easy-to-apply gel-filled syringe.

“We’ve been searching for additional dry eye products to add to our established sales channels for some time. The Zocular product line is ideal for eyecare specialists seeking effective tools to treat their patients’ dry eye and is a perfect complement to Avenova,” NovaBay CEO Justin Hall said in the release. “Zocular products are formulated with a novel, powerful technology to address inflammation at the eyelid margin. Avenova is the only lid and lash antimicrobial spray to be clinically proven to reduce the bacterial load on skin surfaces surrounding the eyes, thus addressing the underlying cause of bacterial dry eye. Both Avenova and Zocular at-home products are completely safe for regular use.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Optical/Ophthalmic Tagged With: novabay

IN CASE YOU MISSED IT

  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development
  • Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China
  • Convatec wins FDA approval for Parkinson’s treatment infusion tech

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS